Orbit Genomics
Boulder, US · Delaware corporation · 2 known investors
Biotech
Founders & leadership
OM
Oerum MikaelExecutive
E(
Elizabeth (Dede) N WillisExecutive
H(
Harold (Skip) GarnerNamed on SEC filing
Board
JS
Julie SilberBoard director
Investors · 2
Competitors · 9
by search overlapGenomeweb25 shared keywordsGenomeWeb's Research Funding section publishes news coverage of research grants and government funding trends in genetics, genomics, and molecular diagnostics. It is an industry news publication serving researchers and organizations in the life sciences.
Polaris Genomics18 shared keywordsPolaris Genomics develops the ADAPT Neuropsychiatric Biomarker Discovery Platform, combining a targeted neuropsychiatric gene panel, analytics engine, and machine learning to identify genomic biomarkers from liquid biopsy for mental health and brain conditions. It serves researchers and pharma, academic, clinical, CRO, and government partners developing biomarker-based diagnostics and therapeutics in neuropsychiatry.
Genomics Plc16 shared keywordsGenomics builds a genotype-phenotype database and genetic risk-prediction tools used to support pharmaceutical drug discovery and clinical trials, as well as population health management and clinical decision support for healthcare providers. It serves life sciences companies and healthcare systems through its Life Sciences and Health & Wellness divisions.
Labcorp15 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
10x Genomics 1-color15 shared keywords10x Genomics develops single-cell and spatial biology technologies, including instruments and assays for whole-transcriptome profiling of tissue samples (e.g. Chromium and its Atera and Xenium spatial platforms). Its tools serve researchers and drug developers studying cancer, immunology, and disease response to advance therapies.
NeoGenomics14 shared keywordsNeoGenomics provides oncology diagnostics and laboratory testing, offering over 500 tests across modalities including molecular testing, IHC, flow cytometry, FISH, next-generation sequencing, and comprehensive genomic profiling for solid tumors and hematologic cancers. It serves oncologists, patients, and biopharma partners in the US, supporting clinical care as well as drug development and clinical trials.
Inside Precision Medicine14 shared keywordsInside Precision Medicine is a news and media outlet covering precision medicine, oncology, genomics, diagnostics, and translational research. It publishes articles, webinars, and a podcast series aimed at researchers and professionals in the precision medicine field.
Phase Genomics13 shared keywordsPhase Genomics develops proximity ligation (Hi-C) kits and computational software for genome assembly, microbiome discovery, structural variant analysis, and genomic profiling across plant, animal, microbe, and human samples. It serves researchers in academia, industry, and clinical settings, offering both laboratory and computational genomics products and services.
Arima Genomics10 shared keywordsArima Genomics is a cancer diagnostics company using 3D genome science and Hi-C sequencing to detect cancer-driving genomic alterations that conventional DNA and RNA profiling methods miss. It develops clinical tests (Aventa) for solid tumors and lymphoma to help guide therapy selection.
Companies competing with Orbit Genomics for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements$780K disclosed across 1 round · 2024
▶$780KraisedJul 2025 · 15 investors · BiotechnologyRule 506(b)
▶$780KraisedJul 2025 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Oerum MikaelDirector
- Harold (Skip) GarnerExecutive Officer, Director
- Elizabeth (Dede) N WillisExecutive Officer, Director
- Julie SilberDirector
- Offering amount
- $2M
- Amount sold
- $780K
- Minimum investment
- $5K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Orbit Genomics's investors?
- Orbit Genomics's investors include Rockies Venture Club, Ventac Partners.
- How much funding has Orbit Genomics raised?
- Orbit Genomics has disclosed $780K raised across 1 round.
- Where is Orbit Genomics headquartered?
- Orbit Genomics is headquartered in Boulder, US.